CLOV vs WKHS

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Aug 03, 2026

CLOV

48.9
AI Score
VS
WKHS Wins

WKHS

54.2
AI Score

Investment Advisor Scores

CLOV

49score
Recommendation
HOLD

WKHS

54score
Recommendation
HOLD

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric CLOV WKHS Winner
Revenue 749.19M 4.33M CLOV
Net Income 27.33M -19.88M CLOV
Net Margin 3.6% -459.3% CLOV
Operating Income 27.33M -21.10M CLOV
ROE 8.1% -75.9% CLOV
ROA 3.9% -19.4% CLOV
Total Assets 697.73M 102.74M CLOV
Current Ratio 1.33 1.23 CLOV
Free Cash Flow 107.04M -16.64M CLOV

Relative Price Performance (Last 90 Days)

CLOV 1M: -18.9% · 3M: +57.4% WKHS 1M: +15.9% · 3M: -4.8%

Current Technical Phase

CLOV

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 44

RSI (14): 44.0 · Price: $4.27

WKHS

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 59

RSI (14): 59.3 · Price: $3.09

Fundamentals Snapshot

Metric CLOV WKHS
Market Cap
Forward P/E 41.7 -1.6
Trailing P/E
Revenue (TTM)
Revenue Growth 0.6% 2.8%
Gross Margin 0.2% -0.7%
Operating Margin 0.0% -4.9%
EPS -0.12 -7.63
Dividend Yield

Frequently Asked Questions

Based on our detailed analysis, WKHS is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.